Denali Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-16,222
Closed -$711K – 325
2025
Q4
$711K Buy
16,222
+5,300
+49% +$219K 0.08% 218
2025
Q3
$451K Buy
10,922
+800
+8% +$32.2K 0.05% 238
2025
Q2
$446K Sell
10,122
-109
-1% -$4.36K 0.05% 241
2025
Q1
$378K Sell
10,231
-2,400
-19% -$85.5K 0.04% 258
2024
Q4
$421K Buy
12,631
+4,200
+50% +$136K 0.04% 248
2024
Q3
$219K Buy
+8,431
New +$210K 0.02% 270
2023
Q4
– Sell
-1,700
Closed -$37.1K – 468
2023
Q3
$37.1K Buy
1,700
+1,679
+7,995% +$35.1K 0.01% 304
2023
Q2
$401 Hold
21
– – ﹤0.01% 468
2023
Q1
$408 Sell
21
-679
-97% -$11.8K ﹤0.01% 432
2022
Q4
$11.2K Hold
700
– – ﹤0.01% 318
2022
Q3
$11K Hold
700
– – 0.01% 308
2022
Q2
$15K Hold
700
– – 0.01% 316
2022
Q1
$16K Hold
700
– – 0.01% 320
2021
Q4
$13K Hold
700
– – ﹤0.01% 330
2021
Q3
$15K Sell
700
-5,000
-88% -$92.8K 0.01% 223
2021
Q2
$104K Sell
5,700
-800
-12% -$18.7K 0.04% 159
2021
Q1
$147K Sell
6,500
-21,100
-76% -$477K 0.05% 186
2020
Q4
$554K Sell
27,600
-5,500
-17% -$115K 0.09% 198
2020
Q3
$809K Buy
33,100
+1,200
+4% +$28K 0.16% 148
2020
Q2
$757K Buy
+31,900
New +$739K 0.15% 169

Other funds holding EXEL

Denali Advisors's EXEL Position: Q1 2026 in Review

Denali Advisors sold out of Exelixis (EXEL) in Q1 2026, closing a stake of 16,222 shares — an estimated $711K sold.

Denali Advisors first reported a position in EXEL in Q2 2020 and held it in 20 quarters. The position peaked at $809K in Q3 2020. 701 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Denali Advisors reported no remaining Exelixis position as of Q1 2026 after selling out during the quarter.
  • Denali Advisors sold 16,222 Exelixis shares in Q1 2026, an estimated $711K.
  • Denali Advisors first reported a position in Exelixis in Q2 2020 and held it in 20 quarters.
  • Denali Advisors's Exelixis position peaked at $809K in Q3 2020.
  • 701 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Denali Advisors's 13F filing for Q1 2026, filed 8 May 2026.